Compounds > betaxolol

betaxolol and albuterol

betaxolol has been researched along with albuterol in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (26.67)	18.7374
1990's	2 (13.33)	18.2507
2000's	5 (33.33)	29.6817
2010's	4 (26.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H	1
Aué, GH; Bultsma, T; IJzerman, AP; Linschoten, MR; Timmerman, H	1
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kaik, G; Palminteri, R	1
Curtis-Prior, PB; Tan, S	1
Fulton, J; MacDonald, A; MacDonald, E; McLaughlin, DP; Scott, PJ	1
Alda, O; Alvarez-Guerra, M; Garay, RP	1
Ajaltouni, Z; de Haro, L; Kervégant, M; Schmitt, C; Tauber, M; Tichadou, L	1

Reviews

2 review(s) available for betaxolol and albuterol

Article	Year
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists. Journal of medicinal chemistry, 1988, Volume: 31, Issue:11 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship	1988
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

13 other study(ies) available for betaxolol and albuterol

Article	Year
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines. Journal of medicinal chemistry, 1985, Volume: 28, Issue:9 Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Dihydroalprenolol; Ethanolamines; Guanylyl Imidodiphosphate; Hydrogen-Ion Concentration; Muscles; Propanolamines; Receptors, Adrenergic, beta; Structure-Activity Relationship	1985
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol. European journal of clinical pharmacology, 1983, Volume: 24, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Albuterol; Betaxolol; Blood Pressure; Bronchi; Double-Blind Method; Female; Heart Rate; Humans; Male; Plethysmography, Whole Body; Propanolamines; Propranolol; Time Factors	1983
Characterization of the beta-adrenoceptor of the adipose cell of the rat. International journal of obesity, 1983, Volume: 7, Issue:5 Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Betaxolol; Dose-Response Relationship, Drug; Isoproterenol; Lipolysis; Norepinephrine; Practolol; Prenalterol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta	1983
Effects of catecholamines on isolated human colonic smooth muscle. Journal of autonomic pharmacology, 1996, Volume: 16, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Analysis of Variance; Betaxolol; Catecholamines; Colon; Dose-Response Relationship, Drug; Humans; Isoproterenol; Muscle Contraction; Muscle, Smooth; Norepinephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta	1996
Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat. Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 355, Issue:6 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Betaxolol; Blood Pressure; Celiprolol; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2	1997
[Clonidine poisoning in a child: a case report]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2014, Volume: 21, Issue:11 Topics: Adrenergic alpha-2 Receptor Agonists; Albuterol; Antihypertensive Agents; Betaxolol; Blood Pressure; Child; Clonidine; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Overdose; Drug Therapy, Combination; Heart Rate; Humans; Male; Medication Errors; Naloxone	2014